ITU Medicines and End of Life Care Medicines for Covid-19 preparedness.
key details
| Value | £212,272 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 15 Dec 2021 |
| Contract start | 31 Jan 2022 |
| Contract end | 30 Jan 2023 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-d810deb6-5b97-46ab-a606-29801a84d025 |
Awards (3)
This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £212,272.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £212,272 | 21 Feb 2022 | active |
| Aguettant Ltd shared | £212,272 | 21 Feb 2022 | active |
| Typharm Limited shared | £212,272 | 21 Feb 2022 | active |
description
Award for the supply of ITU Medicines and End of Life Care Medicines for Covid-19 preparedness.The Authority seeks to top up the Stockpile holdings of Midazolam 50mg/10ml vial (EOL) and Noradrenaline 8mg/8ml for infs Amp (ITU) medicines in preparations for further waves of Covid 19 in Winter 2021/ Spring 2022.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 12 Apr 2023 | Award (award) | · | 217b4189-2abb-4d8a-9c53-435a01638498-634513 |
more from UK Health Security Agency
- Contingent labour contract for FOI team · £59,457 · 8 Sept 2026
- Q Pulse eQMS Software and Service · £74,888 · 7 Sept 2026
- Quality control and assurance services · £500,000 · 3 Sept 2026
- Egress Protect and Egress Workspace licences · £561,600 · 3 Sept 2026
- Tenable - Vulnerability Monitoring solution · £383,572 · 3 Sept 2026
- Provision of Colony Counter ProtoCOL 3 PLUS · £16,092 · 1 Sept 2026
- Request for information - Liquid Handling Robots · 28 Aug 2026
- Service Now Licenses Renewal 26-30 · £5,678,373 · 27 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.